First review round: 4.7 weeks. Overall rating: 3 (good).
Handling was prompt and reviewers were fair. The reviews were mostly positive, which the editor acknowledged, but after discussion among all Lancet editors they decided it did not fit within the scope of the journal because it was not yet immediately clinically applicable. This felt like a decision that could have been made before sending it out for review.